Multiple Myeloma Awareness Month

Multiple Myeloma Awareness Month

Multiple myeloma is diagnosed in approximately 588,161 people per year worldwide and in an estimated 34,920 people in US. Multiple myeloma accounts for almost 2% of cancer diagnosed and 10% of all hematological malignancies. The 5-year survival has been increased over the past decades with the introduction of new targeted therapies and transplant techniques. Immunohistochemistry plays a very important role in making diagnosis and differential diagnosis, classifying multiple myeloma, and making therapeutic decisions.





Order Now: